President Donald Trump has given generic-drug manufacturers a choice – add U.S. capacity within two years or face tariffs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results